Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jane McKeating

Jane McKeating

Professor of Molecular Virology

McKeating Group

Viruses are intracellular pathogens and understanding host pathways that define susceptibility to infection and disease are essential for the design of new therapies. Viral replication is shaped by the cellular microenvironment and current projects focus on the spatial mapping of infected cells at single-cell resolution to identify the key factors that regulate virus tissue tropism.

RESEARCH THEMES

Hepatitis viruses

Chronic hepatitis B and D viruses are a major cause of liver disease and cancer, with limited curative treatments. The liver is a naturally hypoxic organ and we have identified a role for hypoxia inducible factors to activate viral transcription. Our goal is to understand the hepatocyte-intrinsic and extrinsic pathways that define host susceptibility to these viruses. The frequency of infected cells in the liver is low and bulk RNA-sequencing approaches frequently overlook their complex transcriptomes. We have developed spatial transcriptional profiling methods to identify HBV and HDV infected hepatocytes and their uninfected neighbours. When combined with single molecule resolution imaging of viral RNAs, these exciting technologies allow us to study virus-host interplay at unprecedented detail.

Respiratory viruses

Globally respiratory infections are responsible for approximately 4.25 million deaths/year (pre-COVID), mostly in children and the elderly. Viruses are responsible for the majority of these infections and developing broadly active tools to fight these viruses is a priority. We have shown that hypoxia suppresses SARS-CoV-2 replication and inflammatory responses. We have recently extended these observations to Respiratory Syncytial virus and shown our HIF mimetic drugs potently inhibit infection by activating innate sensing and Interferon-signalling.

Research Funding
The McKeating lab are delighted to be amongst the recipients of a Wellcome Trust Discovery Award together with additional funding from the Medical Research Council and the Chinese Academy of Medical Science Oxford Institute. We aim to deliver an ambitious programme of research, applying cutting edge spatial technologies to study the mechanisms of persistence in both acute and chronic viral infection. We are excited to announce that we are welcoming applications for funded post-doctoral research positions. 

Key publications

More publications